Journal
BLOOD
Volume 138, Issue 9, Pages 744-746Publisher
AMER SOC HEMATOLOGY
DOI: 10.1182/blood.2021012186
Keywords
-
Categories
Ask authors/readers for more resources
The study demonstrates the crucial role of PD-L1 in delaying neutrophil apoptosis at the site of inflammation by activating the PI3K-AKT survival pathway.
In this issue of Blood, Wang et al uncover a key role that programmed death ligand 1 (PD-L1) plays in delaying neutrophil apoptosis at the site of inflammation by activation of the phosphatidylinositol 3-kinase (PI3K)-AKT survival pathway.(1)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available